E-syt1 Inhibition Improves Muscle Function in Sarcopenic Obesity
Author Information
Author(s): Song Chao, Wu Zheng, Liu Guoming, Xu Yiyang, Deng Zhibo, Xiu Yu, Zhang Rongsheng, Yang Linhai, Zhang Yifei, Yu Guoyu, Su Yibin, Luo Jun, He Bingwei, Xu Jie, Dai Hanhao
Primary Institution: Fujian Medical University
Hypothesis
E-syt1 plays a critical role in regulating skeletal muscle metabolism and may be a target for treating sarcopenic obesity.
Conclusion
Inhibiting E-syt1 enhances muscle mass, mitochondrial function, and exercise capacity in a model of sarcopenic obesity.
Supporting Evidence
- E-syt1 levels were significantly higher in aged skeletal muscle compared to young muscle.
- Silencing E-syt1 enhanced myoblast proliferation and differentiation.
- E-syt1 overexpression led to mitochondrial dysfunction and impaired mitophagy.
- Inhibition of E-syt1 improved exercise capacity and muscle mass in OVX mice.
- Mitophagic flux was reduced in cells overexpressing E-syt1.
Takeaway
This study found that blocking a protein called E-syt1 can help older mice build stronger muscles and improve their ability to exercise.
Methodology
The study used in vivo and in vitro experiments to assess the effects of E-syt1 on muscle metabolism and function.
Limitations
The exact mechanism of E-syt1-induced defective autophagy remains unclear, and the study did not explore gender differences in the results.
Participant Demographics
The study involved OVX mice, a model for estrogen deficiency-induced muscle atrophy.
Statistical Information
P-Value
0.0116
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website